Efficacy and Safety of VisuEvo® and Cationorm® for the Treatment of Evaporative and Non-Evaporative Dry Eye Disease: A Multicenter, Double-Blind, Cross-Over, Randomized Clinical Trial

scientific article published on 18 June 2020

Efficacy and Safety of VisuEvo® and Cationorm® for the Treatment of Evaporative and Non-Evaporative Dry Eye Disease: A Multicenter, Double-Blind, Cross-Over, Randomized Clinical Trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2147/OPTH.S258081
P932PMC publication ID7308118
P698PubMed publication ID32606580

P50authorAnna CarettiQ42827183
Paolo FogagnoloQ85234037
Chiara QuisisanaQ96818219
P2093author name stringLuca Rossetti
Daniele Marchina
Ettore Melardi
Michele Dei Cas
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P921main subjecteye diseaseQ3041498
P304page(s)1651-1663
P577publication date2020-06-18
P1433published inClinical OphthalmologyQ5133782
P1476titleEfficacy and Safety of VisuEvo® and Cationorm® for the Treatment of Evaporative and Non-Evaporative Dry Eye Disease: A Multicenter, Double-Blind, Cross-Over, Randomized Clinical Trial
P478volume14

Search more.